Decreased pulse pressure during hemodialysis is associated with improved 6-month outcomes

Kidney International

Volumn 76, Issue 10, 2009, Pages 1098-1107

  Inrig, Jula K ^a,b   Patel, Uptal D ^b,c   Toto, Robert D ^a   Reddan, Donal N ^d   Himmelfarb, Jonathan ^e   Lindsay, Robert M ^f   Stivelman, John ^g   Winchester, James F ^h   Szczech, Lynda A ^b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f LONDON HEALTH SCIENCES CENTRE   (Canada)

^g Northwest Kidney Centers   (United States)

^h BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

End stage renal disease; Hemodialysis; Intradialytic blood pressure; Morbidity and mortality; Outcomes; Pulse pressure

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE PRESSURE; SENSITIVITY ANALYSIS; TREATMENT OUTCOME;

AGED; BLOOD PRESSURE; COHORT STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 70350651312     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.340     Document Type: Article

References (41)

1. US Renal Data Systems. USRDS 2007 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, 2007.
2. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005; 45(Suppl 4): s49-s59, s69-s75.
3. Millar JA, Lever AF, Burke V. Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial. J Hypertens 1999; 17: 1065-1072.
4. Benetos A, Rudnichi A, Safar M et al. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension 1998; 32: 560-564.
5. Domanski M, Norman J, Wolz M et al. Cardiovascular risk assessment using pulse pressure in the first national health and nutrition examination survey (NHANES I). Hypertension 2001; 38: 793-797.
6. Wang JG, Staessen JA, Franklin SS et al. Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome. Hypertension 2005; 45: 907-913.
7. Klassen PS, Lowrie EG, Reddan DN et al. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA 2002; 287: 1548-1555.
8. Tozawa M, Iseki K, Iseki C et al. Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis. Kidney Int 2002; 61: 717-726.
9. Blacher J, Guerin AP, Pannier B et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434-2439.
10. London GM, Blacher J, Pannier B et al. Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001; 38: 434-438.
11. Guerin AP, Blacher J, Pannier B et al. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001; 103: 987-992.
12. London GM, Pannier B, Guerin AP et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 2001; 12: 2759-2767.
13. Agarwal R, Peixoto AJ, Santos SFF et al. Pre-and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol 2006; 1: 389-398.
14. Cice G, Ferrara L, D'Andrea A et al. Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial. J Am Coll Cardiol 2003; 41: 1438-1444.
15. Cice G, Ferrara L, Di Benedetto A et al. Dilated cardiomyopathy in dialysis patients-beneficial effects of carvedilol: a double-blind, placebo-controlled trial. J Am Coll Cardiol 2001; 37: 407-411.
16. Takahashi A, Takase H, Toriyama T et al. Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis-a randomized study. Nephrol Dial Transplant 2006; 21: 2507-2512.
17. Zannad F, Kessler M, Lehert P et al. Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. Kidney Int 2006; 70: 1318-1324.
18. Suzuki H, Kanno Y, Sugahara S et al. Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: an open-label randomized controlled trial. Am J Kidney Dis 2008; 52: 501-506.
19. Ichihara A, Hayashi M, Kaneshiro Y et al. Low doses of losartan and trandolapril improve arterial stiffness in hemodialysis patients. Am J Kidney Dis 2005; 45: 866-874.
20. Shibasaki Y, Masaki H, Nishiue T et al. Angiotensin II type 1 receptor antagonist, losartan, causes regression of left ventricular hypertrophy in end-stage renal disease. Nephron 2002; 90: 256-261.
21. Chan CT, Floras JS, Miller JA et al. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 2002; 61: 2235-2239.
22. Culleton BF, Walsh M, Klarenbach SW et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 2007; 298: 1291-1299.
23. Inrig JK, Oddone EZ, Hasselblad V et al. Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients. Kidney Int 2007; 71: 454-461.
24. Santos SF, Mendes RB, Santos CA et al. Profile of interdialytic blood pressure in hemodialysis patients. Am J Nephrol 2003; 23: 96-105.
25. Cheigh JS, Milite C, Sullivan JF et al. Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis 1992; 19: 453-459.
26. Boon D, van Montfrans GA, Koopman MG et al. Blood pressure response to uncomplicated hemodialysis: the importance of changes in stroke volume. Nephron Clin Pract 2004; 96: c82-c87.
27. Chaignon M, Chen WT, Tarazi RC et al. Blood pressure response to hemodialysis. Hypertension 1981; 3: 333-339.
28. Salahudeen AK, Fleischmann EH, Bower JD et al. Underweight rather than overweight is associated with higher prevalence of hypertension: BP vs BMI in haemodialysis population. Nephrol Dial Transplant 2004; 19: 427-432.
29. Salahudeen AK, Fleischmann EH, Bower JD. Impact of lower delivered Kt/V on the survival of overweight patients on hemodialysis. Kidney Int 1999; 56: 2254-2259.
30. Abbott KC, Glanton CW, Trespalacios FC et al. Body mass index, dialysis modality, and survival: analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study. Kidney Int 2004; 65: 597-605.
31. Wolfe RA, Ashby VB, Daugirdas JT et al. Body size, dose of hemodialysis, and mortality. Am J Kidney Dis 2000; 35: 80-88.
32. Kopple JD, Zhu X, Lew NL et al. Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int 1999; 56: 1136-1148.
33. Lowrie EG, Li Z, Ofsthun N et al. Body size, dialysis dose and death risk relationships among hemodialysis patients. Kidney Int 2002; 62: 1891-1897.
34. Kyriazis J, Stamatiadis D, Mamouna A. Intradialytic and interdialytic effects of treatment with 1.25 and 1.75Mmol/l of calcium dialysate on arterial compliance in patients on hemodialysis. Am J Kidney Dis 2000; 35: 1096-1103.
35. Leunissen KM, van den Berg BW, van Hooff JP. Ionized calcium plays a pivotal role in controlling blood pressure during haemodialysis. Blood Purif 1989; 7: 233-239.
36. Gabutti L, Bianchi G, Soldini D et al. Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids. Nephrol Dial Transplant 2009; 24: 973-981.
37. Sherman RA, Bialy GB, Gazinski B et al. The effect of dialysate calcium levels on blood pressure during hemodialysis. Am J Kidney Dis 1986; 8: 244-247.
38. Maynard JC, Cruz C, Kleerekoper M et al. Blood pressure response to changes in serum ionized calcium during hemodialysis. Ann Intern Med 1986; 104: 358-361.
39. Agarwal R, Andersen MJ, Bishu K et al. Home blood pressure monitoring improves the diagnosis of hypertension in hemodialysis patients. Kidney Int 2006; 69: 900-906. (Pubitemid 43297902)
40. Agarwal R, Metiku T, Tegegne GG et al. Diagnosing hypertension by intradialytic blood pressure recordings. Clin J Am Soc Nephrol 2008; 3: 1364-1372.
41. Reddan DN, Szczech LA, Hasselblad V et al. Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial. J Am Soc Nephrol 2005; 16: 2162-2169.